Home > Insider Trading > Filing (0001104659-12-007036)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1382911	Orexigen Therapeutics Inc.	OREX	Pharmaceutical Preparations (2834)	651178822

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1280249	Iii K Daniel Turner	C/O Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Court, Suite 200 La Jolla CA 92037		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-12-22	28,602	$1.45	177,958	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2011-12-22	28,602	$1.45	377,958	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-12-22	28,602	$14.49	286,020	$0.00
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-12-22	28,602	$14.49	286,020	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,602	2011-12-22	2021-12-22	No	4	P	Indirect
28,602	2011-12-22	2021-12-22	No	4	P	Indirect

Footnotes

The Common Stock and Warrants were sold as units at a purchase price of $15.94 per unit, each unit consisting of one share of Common Stock and one Warrant to purchase ten shares of Common Stock.
The reported securities are owned directly by Montreux Equity Partners II SBIC, L.P. ("MEP II"). The voting and disposition of the shares held by MEP II are determined by Montreux Equity Management II SBIC, LLC ("MEM II"). Mr. Turner is a managing member of MEM II. Mr. Turner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
The reported securities are owned directly by Montreux Equity Partners III SBIC, L.P. ("MEP III"). The voting and disposition of the shares held by MEP III are determined by Montreux Equity Management III SBIC, LLC ("MEM III"). Mr. Turner is a managing member of MEM III. Mr. Turner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.